Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
C Max |
4950000.0 |
ug.h/ml |
4950.0 |
ug.h/ml |
Oral multiple dose; |
DRUGBANK |
C Max |
9610000.0 |
ug.h/ml |
9610.0 |
ug.h/ml |
Oral multiple dose; |
DRUGBANK |
C Max |
4000000.0 |
ug.h/ml |
4000.0 |
ug.h/ml |
Oral multiple dose; |
DRUGBANK |
T Max |
2.0 |
h |
2 |
h |
PO, oral; |
DRUGBANK |
Clearance |
6.7 |
L/h |
6.7 |
L/h |
apparent clearance; PO, oral; |
DRUGBANK |
Volume of Distribution |
338.0 |
L |
338.0 |
L |
Total volume of distribution; |
DRUGBANK |
Volume of Distribution |
72.2 |
L |
72.2 |
L |
Total volume of distribution; |
DRUGBANK |
Half-life |
35.5 |
h |
35.5 |
h |
elimination half-life; sickle cell disease; patients; |
DRUGBANK |
Half-life |
1440.0 |
h |
60 |
day |
|
DRUGBANK |
Half-life |
50.0 |
h |
50 |
h |
elimination half-life; sickle cell disease; patients; different study; |
DRUGBANK |
Half-life |
73.0 |
h |
61-85 |
h |
elimination half-life; normal,healthy; patients; different study; |
DRUGBANK |
Eliminate Route |
62.6 |
% |
62.6 |
% |
Faeces excretion; PO, oral; |
DRUGBANK |
Eliminate Route |
35.5 |
% |
35.5 |
% |
Urinary excretion; PO, oral; |
DRUGBANK |
Eliminate Route |
20.8 |
% |
~20.8 |
% |
Faeces excretion; PO, oral; Unchanged drug; |
DRUGBANK |
Eliminate Route |
0.0300 |
% |
~0.03 |
% |
Urinary excretion; PO, oral; Unchanged drug; |
DRUGBANK |
Protein Binding |
99.8 |
% |
99.8 |
% |
high protein binding; |
DRUGBANK |